Present and future of endoscopy precision for inflammatory bowel disease
- PMID: 37643635
- PMCID: PMC12136274
- DOI: 10.1111/den.14672
Present and future of endoscopy precision for inflammatory bowel disease
Abstract
Several advanced imaging techniques are now available for endoscopists managing inflammatory bowel disease (IBD) patients. These tools, including dye-based and virtual chromoendoscopy, probe-based confocal laser endomicroscopy and endocytoscopy, are increasingly innovative applications in clinical practice. They allow for a more in-depth and refined evaluation of the mucosal and vascular bowel surface, getting closer to histology. They have demonstrated a remarkable ability in assessing intestinal inflammation, histologic remission, and predicting relapse and favorable long-term outcomes. In addition, the future application of molecular endoscopy to predict biological drug responses has yielded preliminary but encouraging results. Furthermore, these techniques are crucial in detecting and characterizing IBD-related dysplasia, assisting endoscopic mucosal resection and submucosal dissection towards a surgery-sparing approach. Artificial intelligence (AI) holds great potential in this promising landscape, as it can provide an objective and reproducible assessment of inflammation and dysplasia. Moreover, it can improve the prediction of outcomes and aid in subsequent therapeutic decision-making. This review aims to summarize the promising role of state-of-the-art advanced endoscopic techniques and related AI-enabled models for managing IBD, paving the way for precision medicine.
Keywords: artificial intelligence; chromoendoscopy; confocal laser endomicroscopy; endocytoscopy; precision medicine.
© 2023 The Authors. Digestive Endoscopy published by John Wiley & Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.
Conflict of interest statement
Author M.I. is an Associate Editor of
Figures


Similar articles
-
Next-Generation Endoscopy in Inflammatory Bowel Disease.Diagnostics (Basel). 2023 Jul 31;13(15):2547. doi: 10.3390/diagnostics13152547. Diagnostics (Basel). 2023. PMID: 37568910 Free PMC article. Review.
-
New endoscopic tools in inflammatory bowel disease.United European Gastroenterol J. 2022 Dec;10(10):1103-1112. doi: 10.1002/ueg2.12316. Epub 2022 Oct 12. United European Gastroenterol J. 2022. PMID: 36225117 Free PMC article. Review.
-
Evolution and New Horizons of Endoscopy in Inflammatory Bowel Diseases.J Clin Med. 2022 Feb 7;11(3):872. doi: 10.3390/jcm11030872. J Clin Med. 2022. PMID: 35160322 Free PMC article. Review.
-
Role of ultra-high definition endoscopy (endomicroscopy and endocytoscopy) and real-time histologic examination in inflammatory bowel disease: Scoping review.Dig Endosc. 2024 Mar;36(3):274-289. doi: 10.1111/den.14659. Epub 2023 Sep 6. Dig Endosc. 2024. PMID: 37573562
-
Endoscopic imaging in inflammatory bowel disease: current developments and emerging strategies.Expert Rev Gastroenterol Hepatol. 2021 Feb;15(2):115-126. doi: 10.1080/17474124.2021.1840352. Epub 2020 Oct 31. Expert Rev Gastroenterol Hepatol. 2021. PMID: 33094654 Review.
Cited by
-
Artificial intelligence-enabled advanced endoscopic imaging to assess deep healing in inflammatory bowel disease.eGastroenterology. 2024 Aug 1;2(3):e100090. doi: 10.1136/egastro-2024-100090. eCollection 2024 Sep. eGastroenterology. 2024. PMID: 39944363 Free PMC article. Review.
-
The impact of artificial intelligence on the endoscopic assessment of inflammatory bowel disease-related neoplasia.Therap Adv Gastroenterol. 2025 Jun 23;18:17562848251348574. doi: 10.1177/17562848251348574. eCollection 2025. Therap Adv Gastroenterol. 2025. PMID: 40556746 Free PMC article. Review.
-
Endo-Histo foundational fusion model: a novel artificial intelligence for assessing histologic remission and response to therapy in ulcerative colitis clinical trial.J Crohns Colitis. 2025 Jul 3;19(7):jjaf108. doi: 10.1093/ecco-jcc/jjaf108. J Crohns Colitis. 2025. PMID: 40581339 Free PMC article.
-
Artificial intelligence in inflammatory bowel disease endoscopy - a review of current evidence and a critical perspective on future challenges.Therap Adv Gastroenterol. 2025 Jul 13;18:17562848251350896. doi: 10.1177/17562848251350896. eCollection 2025. Therap Adv Gastroenterol. 2025. PMID: 40661220 Free PMC article. Review.
-
Epithelial neutrophil localization and tight junction Claudin-2 expression are innovative outcome predictors in inflammatory bowel disease.United European Gastroenterol J. 2024 Nov;12(9):1155-1166. doi: 10.1002/ueg2.12677. Epub 2024 Oct 3. United European Gastroenterol J. 2024. PMID: 39361538 Free PMC article.
References
-
- Turner D, Ricciuto A, Lewis A et al. TSTRIDE‐II: An update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): Determining therapeutic goals for treat‐to‐target strategies in IBD. Gastroenterology 2021; 160: 1570–1583. - PubMed
-
- Iacucci M, Furfaro F, Matsumoto T et al. Advanced endoscopic techniques in the assessment of inflammatory bowel disease: New technology, new era. Gut 2019; 68: 562–572. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources